Analytical Data
-
基因名
IL-23
- Application
-
别名
IL-23；Interleukin-23 receptor
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NPF7
-
表达区间
23-328aa
-
氨基酸序列
IWELKKDVYV VELDWYPDAP GEMVVLTCDT PEEDGITWTL DQSSEVLGSG KTLTIQVKEF GDAGQYTCHK GGEVLSHSLL LLHKKEDGIW STDILKDQKE PKNKTFLRCE AKNYSGRFTC WWLTTISTDL TFSVKSSRGS SDPQGVTCGA ATLSAERVRG DNKEYEYSVE CQEDSACPAA EESLPIEVMV DAVHKLKYEN YTSSFFIRDI IKPDPPKNLQ LKPLKNSRQV EVSWEYPDTW STPHSYFSLT FCVQVQGKSK REKKDRVFTD KTSATVICRK NASISVRAQD RYYSSSWSEW ASVPCSGSTS GSGKPGSGEG STKGRAVPGG SSPAWTQCQQ LSQKLCTLAW SAHPLVGHMD LREEGDEETT NDVPHIQCGD GCDPQGLRDN SQFCLQRIHQ GLIFYEKLLG SDIFTGEPSL LPDSPVGQLH ASLLGLSQLL QPEGHHWETQ QIPSLSPSQP WQRLLLRFKI LRSLQAFVAV AARVFAHGAA TLSP
-
分子量
70 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Interleukin-23 (IL-23) is a crucial cytokine that plays a significant role in the immune response, particularly in the differentiation and maintenance of T-helper 17 (Th17) cells, which are involved in various autoimmune and inflammatory diseases. Research on IL-23 has intensified due to its implication in conditions such as psoriasis, inflammatory bowel disease, and rheumatoid arthritis. The recombinant form of IL-23 has garnered interest not only for its potential therapeutic applications but also for its use in basic research to better understand immune pathways and cytokine signaling. By producing IL-23 as a recombinant protein, researchers can investigate its biological functions, interaction with other immune molecules, and role in disease pathogenesis. Moreover, recombinant IL-23 is valuable for developing and testing novel therapeutics aimed at modulating immune responses in autoimmune disorders. Studies involving this cytokine have provided insights into the complex signaling networks of the immune system, paving the way for targeted treatments that may offer better efficacy and safety profiles than traditional approaches. Overall, the exploration of IL-23 and its recombinant forms holds promise for advancing our understanding of immune regulation and developing innovative therapies for immune-mediated diseases.
